Toward a chronotherapy of ovarian cancer. Part III: Salivary CA125 for chronochemotherapy by efficacy.
University of Minnesota, Minneapolis.
G
G
Cornélissen
F
F
Halberg
E
E
Halberg
C
C
Bingham
E
E
Haus
R C
RC
Bast
S
S
Fujii
H J
HJ
Long
F
F
Halberg
K
K
Tamura
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000378:metabolism; D002909:Chronobiology Phenomena; D002945:Cisplatin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000276:immunology* / Q000517:prevention & control; D017239:Paclitaxel / Q000008:administration & dosage; D012463:Saliva / Q000276:immunology
D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D017239:Paclitaxel; D002945:Cisplatin